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Abstract: Staphylococcus aureus is a major human
pathogen causing a wide spectrum of nosocomial and
community-associated infections with high morbidity and
mortality. S. aureus generates a large number of virulence
factors whose timing and expression levels are precisely
tuned by regulatory proteins and RNAs. The aptitude of
bacteria to use RNAs to rapidly modify gene expression,
including virulence factors in response to stress or
environmental changes, and to survive in a host is an
evolving concept. Here, we focus on the recently
inventoried S. aureus regulatory RNAs, with emphasis on
those with identified functions, two of which are directly
involved in pathogenicity.
Introduction
Staphylococcus aureus belongs to the normal human flora. About
one in three healthy individuals are colonized asymptomatically
with S. aureus in the nostrils without any associated disease.
However, S. aureus is also a leading cause of hospital-and community-
acquired infections worldwide [1]. This potent Gram-positive
pathogen can grow in any part of the human body, and also
propagates in other animals. The severity and locations of infections
vary widely, from minor skininfections to deep-seated infections such
as endocarditis, bone and joint infections, or severe pneumonia.
Concern about S. aureus infections is heightened because of the
emergence and spread of hypervirulent, drug-resistant, and commu-
nity-acquired strains [2]. The pathogenesis of S. aureus is intricate and
relies on an arsenal of virulence-associated factors including toxins,
adhesins, enzymes, and immune-modulators [3]. These proteins are
delivered in a coordinated manner by sophisticated regulatory
networks. To this end, multiple trans-acting modulators, including
regulatory proteins, secondary metabolites, small peptides, and
RNAs, are brought into play [4,5].
The universality of small, usually non-coding, RNAs (sRNAs)
playing a role in gene regulation in bacteria is now well established
[6,7]. The number of sRNA identified in bacteria has considerably
increased this past decade [8]. Most of them exert regulatory
functions by interacting with proteins and by pairing with mRNAs.
Besides these trans-acting sRNAs, a variety of large mRNA leaders
sense environmental cues or intracellular concentrations of small
metabolites to adopt structures that prevent/activate their extended
transcription or translation. Examples of sRNA-dependent regula-
tions are given in Figure 1. Recent studies on various bacteria
indicated that pervasive transcription generates massive antisense
transcription [9–11]. All these sRNAs are members of regulatory
circuits involved in metabolism, stress adaptation, and virulence.
Although still a recent field, the study of sRNAs has already
extended our knowledge of regulatory circuits in bacteria, in
relation to pathogenesis. In S. aureus, the multifunctional regulatory
RNA, called RNAIII, is a paradigm for RNA-mediated regulation
of virulence genes [12,13]. It is the effector of the accessory gene
regulator (agr) system [4], which controls the switch between the
expression of surface proteins and excreted toxins. Within the last
few years, several reports highlighted the importance and diversity
of staphylococcal sRNAs [14–18]. This review focuses on S. aureus
regulatory RNAs including RNAIII, newly discovered island-
encoded sRNAs, cis-encoded antisense RNAs (asRNA), and cis-
acting regulatory regions of mRNAs. For all these RNAs, their
structural diversityandphylogeneticdistributionisdocumented and
discussed, with emphasis on those for which their targets were
identified and regulatory mechanisms elucidated. Some of these
sRNAs have been demonstrated as tractable targets for compounds
inhibiting S. aureus pathogenesis.
Diversity of sRNAs Expressed from the S. aureus
Genome
The complex structure of RNAIII, the first sRNA reported in S.
aureus, and the intriguing pleiotropic phenotypes associated with its
inactivation, led to the proposal and subsequent demonstration that
RNAIII was a regulatory RNA [12] (cf. below). In 2001, with the
exception of tmRNA, the sRNAs were ignored from the analysis of
the first staphylococcal genome sequences [19]. As sRNAs initially
emerged as major regulators for bacterial physiology in Escherichia coli,
several laboratories engaged in a quest to identify sRNAs in various S.
aureus strains. In 2005, Pichon and Felden demonstrated for the first
time the existence of sRNAs produced by horizontally acquired
genomic islands by identifying seven sRNAs encoded on pathoge-
nicity islands (PIs) in S. aureus [14]. Recently, several publications on
this bacterium have contributed to an impressive catalog of putative
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model organism for sRNA studies. Approaches for identifications
were based on dedicated computing software [14,15,20], Affymetrix
microarrays [21,22], conventional cloning/sequencing of small sized
cDNAs [16], and 454 [17] and Illumina [18] high throughput
sequencing(HTS).ThesRNAgenesarelocatedrandomlyinthecore
genome and mobile accessory elements, and some of them are
present in multiple copies. Besides the housekeeping RNAs (such as
4.5S, RNase P, and tmRNA), 6S RNA, and cis-acting regulatory
sequences, conservation of most sRNAs is restricted to the genus
Staphylococcus, and among them, about 50% are found so far only
within the S. aureus species. Approximately 100 trans-encoded sRNAs,
100 cis-encoded asRNAs, and more than 30 cis-acting regulatory
regions of mRNAs (e.g., riboswitch, T-Box, protein-binding motif)
were discovered to be encoded on the S. aureus chromosome, and nine
sRNAs on the pN315 plasmid. The expression of more than 90 of
these was confirmed by alternative methods such as northern blots,
RNA extremity mapping, or RT-qPCR (Table S1). The HTS study
performed by Beaume et al. [18] confirmed almost all sRNAs from
other studies [14,15,17,20], with the exception of 12 sRNAs that were
reported solely by Abu-Qatouseh et al. [16]. This singularity might
reflect the distance between the unsequenced clinical isolates and the
S. aureus strains in which sRNAs are mainly studied. This observation
may suggest that the sRNA profile is a signatureof a given strain; if in
the case of N315 we are approaching a fullinventory, it isnot the case
for the other S. aureus strains.
Numerous cis-Encoded Antisense RNAs (asRNAs)
These RNAs pair with an extended perfect match to RNAs
expressed from their complementary gene strand (Figure 1D). The
first one identified in S. aureus was shown to control the rolling-circle
replication of plasmid pT181 by transcriptional attenuation [23];
Figure 1. General mechanisms given for several S. aureus regulatory RNAs. (A) S-adenosyl methionine (SAM) riboswitch regulates several
operons encoding enzymes and transporter proteins. SAM binds to an aptamer domain and stabilizes the formation of a terminator hairpin (the
alternate pairings are in red) to arrest transcription [75]. (B) Schematic representation of a T-Box involved in the regulation of aminoacyl-tRNA
synthetases (aaRS). Non aminoacylated tRNA binds to the leader region at two different sites: the anticodon sequence of the tRNA base paired with a
codon-like triplet present in the ‘‘specifier loop’’, and the ACCA end of the tRNA binds to a complementary sequence located in the T-Box motif [82].
This interaction stabilizes an anti-terminator structure allowing transcription of the downstream genes. *The aminoacyl-tRNA synthetases regulated
by this mechanism are the ValRS, MetRS, IleRS, PheRS, GlyRS, SerRS, HisRS, and the AspRS. (C) The SprD pathogenicity island RNA (in red) binds to the
ribosome binding site (The SD is green) of sbi mRNA to repress translation initiation [37]. (D) The RsaOX (in red) (or Teg14as) cis-acting asRNA [17,18]
is complementary to the coding sequence of tnp mRNA and is predicted to induce rapid degradation of tnp mRNA. Both the asRNA and the mRNA
target site are highly folded, suggesting that the pairing is initiated by a loop–loop interaction.
doi:10.1371/journal.ppat.1002006.g001
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asRNAs among the inventoried sRNAs [14,16–18]. Many asRNAs
are expressed from PIs and mobile elements (plasmids or
transposons). Transposable genetic elements are important motors
of genetic variability but can also compromise genome integrity.
Hence, transposition would expectedly be tightly regulated. The
control of transposase synthesis occurs through different mecha-
nisms, one being by asRNAs [24]. Among them, RsaOX is
complementarytothe codingsequenceofSA0062mRNAencoding
a transposase [17] (Figure 1D). Another interesting case is the
control of the IS1181 transposase, which has its gene repeated eight
times in the S. aureus N315 genome. Two small RNAs, Teg17/
RsaOW and Teg24as complementary to the 59 and 39 IS1181
UTRs, respectively, were detected. The expression of Teg17/
RsaOW isconstitutiveduringgrowth[17],and isstrongly enhanced
in response to pH and temperature changes [18]. Interestingly,
these asRNAs (Figures 1D and 2) show predicted structural
similarity to the E. coli ‘‘RNA-OUT’’ asRNA, which regulates tnp
translation of the IS10 insertion element, suggesting that these
asRNAs have beentuned for fastbindingto mRNAs [25–27]. Some
of these asRNAs are surprisingly long; for example, one of them,
which is complementary to SA0620 encoding a secretory antigen,
SsaA-like, exceeds 1 kb [18]. AsRNAs may participate in the
differential expression of genes belonging to the same operon; this
could be the case for two asRNAs that are complementary to capF
and capM mRNA regions of the large cap operon mRNA encoding
enzyme for capsular polysaccharide synthesis [16,18]. Several
overlapping 39UTRs of convergent mRNAs were also detected in
staphylococci, in which the 39UTR of one mRNA overlaps the
mRNA on the opposite strand, and convergent genes share the
same terminator hairpin. Since they pair between each other with
extended perfect matches, these 39UTRs could be categorized as
asRNAs. sRNAs that likely issue from the processing of extended 39
UTRs were also found. How these overlapping and processed
UTRs affect gene expression is unknown [18].
A Global sRNA Expression Variation Associated with a
Phenotype
Small colony variant (SCV) isolates exhibit particular properties
such as host intracellular persistence and the ability to cause
Figure 2. Secondary structures of selected S. aureus sRNAs. The secondary structures of RsaA and RsaE [15] and of SprD [37] were
experimentally determined. The secondary structure of the antisense RNA RsaOX (or Teg14as) is proposed based on computer predictions [17,18].
The genomic locations and flanking genes of the sRNAs are indicated. The known regulatory domains of the sRNA, which bind to mRNA targets, are
in red. The black circled nucleotides are accessible C-rich motifs that are proposed to be crucial for the initial binding with mRNA [15].
doi:10.1371/journal.ppat.1002006.g002
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asRNAs and sRNAs showed differential expression in the SCV
compared to a wild type strain [16]. In addition, SCVs does not
express RNAIII [16,29]. SCVs also repressed an asRNA that
presumably regulates expression of PhoB, an alkaline phosphatase
involved in inorganic ion transport [16]. These variations of
regulatory RNA expression may correlate with electron transport
deficiencies associated with SCVs [28]. Hence, perturbation of
genetic regulatory circuits and their associated effects on virulence
may be a consequence of and/or contribute to the SCV
phenotype.
RNome-Related S. aureus Specificities
S. aureus has a small genome (2.8 M bp) with a low GC
composition (32.8%); these features affect its RNome and it is
likely that the features of sRNA as learned from studies in enteric
bacteria will differ in S. aureus. Specifically, in E. coli and many
other bacteria, RNase E is implicated in the sRNA-dependent
mRNA turnover, and the RNA chaperone Hfq is required for the
activity of most trans-encoded sRNAs and, as shown recently, for a
cis-encoded asRNA [27]. However, S. aureus do not have an RNase
E, but instead possesses RNases J1, J2, and Y functional homologs
[30]. In Bacillus subtilis, a complex resembling the E. coli
degradosome, including the three RNases J1/J2/Y, glycolytic
enzymes (enolase, phosphofructokinase PfkA) and the RNA
helicase CshA were recently reported [31–33]. Homologs of all
these enzymes are present in the staphylococcal strains, but
whether these enzymes form a ‘‘degradosome’’ remains to be
addressed [30]. Concerning Hfq, this protein is not expressed in
several tested S. aureus strains [34,35], and the deletion of its
corresponding gene was thought to have no effect on bacterial
physiology [36]. However, a recent report indicates that in strains
where Hfq is detected, the deletion of its coding gene could result
in decreased toxicity and virulence of S. aureus, leading to the
conclusion that Hfq is a global regulator that controls pathoge-
nicity [35]. In these strains, analyzing more precisely the
regulatory functions of Hfq as well as its involvement on the
characterized sRNA-dependent regulations would be required.
The commitment of Hfq is not straightforward since several strains
in which Hfq is not detected produce toxins and are virulent.
Moreover, Hfq is not required for the reported cases of sRNA-
induced translational repression [13,15,34,37]; in several of these
examples, the sRNAs efficiently bind to the mRNA targets and
form extended pairings that are specifically cleaved by the double-
strand-specific RNase III [13,38,39]. The dispensability of Hfq in
several S. aureus strains could be due, as compared to E. coli, to the
presence of longer ‘‘sRNA–mRNA’’ hybrids that compensate for
low GC content of the pairings [40].
General strategies for the use of RNA-dependent regulation by
bacteria vary according to species as the result of environmental
and evolutionary constraints. For instance, in B. subtilis and S.
aureus, the autocatalytic site-specific cleavage in the 59 UTR of glmS
mRNA, encoding glucosamine 6 phosphate synthase, is stimulated
by the binding of glucosamine-6-phosphate; in E. coli and
Salmonella the glmS gene is regulated by two sRNAs [41–43].
Mechanistic and functional analyses performed on several S. aureus
sRNAs revealed its RNome specificity by pointing out its
differential roles in the regulation of mobile elements, metabolism,
stress adaptation, and virulence.
Pathogenicity Island–Encoded RNAs
Mobile genetic elements have essential roles in genome
evolution. In facultative pathogens such as S. aureus, they mediate
acquisition of antibiotic resistance genes, including the highly
problematic methicillin resistance via the staphylococcal chromo-
some mec cassette (SCCmec), and have conferred a wide range of
adaptive processes for survival in their hosts. Among these
elements, which include phages, genomic islands, transposons,
and plasmids, the horizontally acquired PIs are the repository of
many toxins, adherence and invasion factors, superantigens, and
secretion systems [44,45]. In addition to the protein-coding genes,
several SaPIs including phage-related chromosomal islands encode
and express several sRNAs [14,16–18] (Table 1). Some sRNAs are
present in multiple copies scattered around the S. aureus genome
(up to eight genomic copies; repeated events of horizontal transfer
as well as gene duplications may account for the presence of
multiple copies), and additional copies are on plasmids [14]. The
location of sRNAs on SaPIs suggests that these sRNAs would play
important roles during S. aureus infections.
Although the sRNAs expressed from SaPIs are expected to
regulate expression of genes located on the cognate PI, they could
also establish functional links between the PIs and the core
genome. An example is provided by the SprD RNA, expressed
from PIw (Table 1), which represses translation initiation of the
sbi mRNA encoding an immune-evasion molecule located at a
core genomic locus distant from SprD [37]. A central hairpin
from SprD pairs to the sbi mRNA ribosome binding sites and
prevents translation initiation (Figures 1C and 2). Interestingly,
SprD contributes significantly to causing disease in a mouse
infection model, although this effect is not only linked to the
down-regulation of Sbi production. Moreover, overproducing
SprD in vivo is toxic for the cells and reduces bacterial growth (S.
Chabelskaya, N. Sayed, and B. Felden, unpublished data),
possibly suggesting that SprD targets essential function(s). Since
SprD has a significant impact on virulence, it implies possible
strategies in controlling staphylococcal infections by modulating
SprD expression levels. Additional sRNAs expressed from the PIs
might also be involved in S. aureus pathogenicity, either directly or
via intricate regulatory networks including transcriptional regu-
latory factors.
Among the currently characterized asRNAs expressed in S.
aureus, four are located in PIs and six in the SCCmec mobile
genetic element, all ranging in sizes from 54 to 400 nucleotides
[18]. Most of them have perfect base complementarities with
regions of mRNAs encoding hypothetical protein genes, and are
likely to act as regulators. Two of these sRNAs, Teg152 and SprF,
are fully complementary to SprA1 and SprG sRNAs, respectively
(Table 1): the ‘‘SprA1/Teg152’’ and ‘‘SprG/SprF’’ RNA pairs are
predicted to form type I ‘‘toxin-antitoxin’’ modules in which SprA
and SprG would encode hydrophobic small peptides [46]. These
modules are found in multiple copies in several S. aureus strains,
and several copies are expressed (A. Jousselin, M. L. Pinel, and B.
Felden, unpublished data). The independent transcriptional
activation of the copies allows the production of accurate sRNA
levels for precise functions. SprA1 is a multifunctional RNA with
putative antisense properties since its 3-end can pair with the 39-
UTRs of three mRNA targets [14]. Interestingly, SCCmec carries
determinants other than antibiotic resistance genes, which confer
selective advantages to methicillin-resistant S. aureus (MRSA) in the
host. An sRNA carrying a small ORF was recently identified
within the SCCmec. This ORF encodes a peptide that has pro-
inflammatory and cytolytic characteristics typical of phenol-soluble
modulins (PSM). The PSM-mec peptide had significant impact on
immune evasion and disease, thus revealing a role of methicillin
resistance clusters in staphylococcal pathogenesis [47]. The
expression of the PSM-sRNA (Teg4) was strongly enhanced in
response to oxidative stress [18].
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to Virulence
RNAIII is the effector of the agr system, which functions as a
sensor of population density. The complex cascade of events
orchestrated by agr has been extensively studied (see [4,12] for
review). Briefly, it comprises a density-sensing cassette (agrD and
agrB) and a two-component sensory transduction system (agrA and
agrC) in which autoinducing peptide (AIP), the agrD gene product,
is continuously released in the extracellular environment. Upon
reaching a critical concentration, AIP activates the two-compo-
nent agrA-agrC system, which triggers transcription of RNAIII, of
its own operon, and of genes encoding metabolic factors and PSM
peptides [12,48]. In this cascade, expression of RNAIII is maximal
in the late logarithmic and stationary phase of growth. RNAIII has
the unique property of acting both as an mRNA that encodes the
26-aa delta hemolysin (PSM) peptide, and as a critical regulator
that represses early virulence factors and activates post-exponen-
tially expressed exotoxins (Figure 3). Further genetic, transcrip-
tomic, and proteomic studies revealed that agr belongs to a rich
and complex network of regulatory genes in which agr is both a
target and an effector of regulation (reviewed in [4]). As an
effector, RNAIII governs not only the expression of key virulence
factors including cell wall–associated proteins and exotoxins, but
also numerous two-component systems and global regulators (arl,
sae, srr, rot) and an impressive list of other processes impacting
biofilm formation, peptidoglycan and amino acid metabolism, and
transport pathways [49–51]. These effects are quantitatively but
not qualitatively variable depending on the staphylococcal strain.
For instance, the effect of agr inactivation was more marked on the
transcriptome of NCTC 8325 derivatives as compared to the
UAMS-1 strain [50]. The question as to whether these effects
result from direct or indirect mechanisms has been only solved for
a limited number of genes and benefited from the experimental
determination of RNAIII structure [52]. RNAIII, a highly stable
molecule (half-life .45 min) [38] is characterized by 14 stem-loop
structures and two long helices formed by long-range base pairings
that close off independent structural domains [52]. Specific
domains of RNAIII control the expression of different targets
(Figure 3). The 59 end of RNAIII positively regulates hla
translation (encoding alpha hemolysin) by competing directly with
an intramolecular RNA secondary structure that sequesters the hla
ribosomal binding site (RBS) ([53,54]; Figure 3A). The RNAIII
hairpin H13 and terminator hairpin H14 of the 39 domain, and
hairpin H7 of the central domain, act separately or coordinately to
repress the synthesis of early expressed virulence factors (i.e.,
coagulase, protein A, and the repressor of toxins, Rot) at the post-
transcriptional level by a conserved mechanism with slight
variations (Figure 3C). The common theme is that RNAIII
functions as an asRNA that anneals to target mRNAs, and the
formed complexes result in the repression of translation initiation
and in rapid mRNA degradation triggered by RNase III.
Structures of the complexes depend on the target mRNA, and
may comprise i) an extended duplex between RNAIII and the
RBS of mRNAs (e.g., spa, the peptidoglycan hydrolase LytM, and
SA1000 encoding a fibrinogen-binding protein), or ii) an imperfect
duplex that sequesters the RBS completed by a loop–loop
interaction in the coding region (for coa encoding coagulase), or
two loop–loop interactions, one involving the 59UTR and the
other the RBS (for rot mRNA) ([13,39]; Figure 3). In these three
cases, a single loop–loop interaction is not sufficient for efficient
repression, thus limiting the capacity of RNAIII to act as a
repressor to the mRNA targets that not only possess a Shine and
Dalgarno (SD) sequence complementary to H7, H13, or H14 of







a Exp. Validation References
SaPIn1
Teg21as Antisens to hypot. protein SA1825 . 2064507/2064570 ,63 No RNA sequencing [18]
Teg22as Antisens to hypot. protein SA1830 . 2069004/2069067 ,63 No RNA sequencing [18]
Teg124 Probable b-lactamase/Enterotoxin C3 , 2059473/2059365 ,108 No RNA sequencing [18]
SaPIn2
Sau-63 Hypot. protein/hypot. protein , 436958–437055 ,100 No Northern [16]
SaPIn3
sprA1
b Trunc. transposase/transposase . 1856223–1856978 208 Yes Northern [14]
Teg152
b transposase/trunc.transposase , 1856712–1856658 ,54 No RNA sequencing [18]
sprB Probableb-lactamase/truncated HP , 1866661–1867134 114–118 Yes Northern [18]
sprC Leukotoxin LukE/Hypot. protein , 1871167–1872531 170 Yes Northern [14]
w (Bacteriophage)
sprD Hypot. protein/hypot. protein , 2006878–2007561 142 Yes Northern [37]
sprX(RsaOR) Trunc. amidase/staphylokinase , 2008572–2009085 147 (processed) Yes Northern [17]
sprF
b Holin homolog/hypot.protein . 2010789–2011001 186 Yes Northern [14]
sprG
b Hypot. protein/holin homolog , 2011001–2010789 300 Yes Northern [14]
aExcept for SprD [37], experimental determinations of the 59 and 39 ends were also performed for sprA, sprB, sprC, sprF, sprG, and sprX (unpublished data); the lengths
of the RNAs with no ends mapping are approximate;
bRNA couples (underlined) predicted to encode for type I ‘‘toxin-antitoxin’’ modules [18].
RNA candidates Sau-18 and Sau-6079 within SaPIn2, and Sau-6361, Sau-6473, Sau-7007 from w were predicted but not confirmed by Northern blots [16]. Apart from PIs,
S. aureus RNAs are also expressed from Genomic Islands (Teg31as and Teg147) and from the staphylococcal chromosome cassette ‘‘SCC Mec’’ (Teg4, Teg5as, Teg6as,
Teg7as, Teg8as, Teg10as, Teg14as, Teg118 [18]).
doi:10.1371/journal.ppat.1002006.t001
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the capacity to form an extended duplex. As discussed above, the
RNA-binding protein Hfq, which is an important RNA chaperone
in several species [55], is not involved in the RNAIII-dependent
regulatory processes, although Hfq binds to RNAIII in vitro [38].
With the exception of hla translational activation, all the direct
effects of RNAIII lead to repression of mRNA targets. However,
as Rot is a transcriptional regulatory protein, its repression by
RNAIII results in the indirect transcriptional regulation of many
genes, including activation of alpha-toxin and repression of protein
A, both of which are also directly regulated by RNAIII [56]. These
complex regulatory circuits involve several feed-forward loops
(Figure 4) that regulate expression via RNAIII and Rot at both the
transcriptional and post-transcriptional levels. For repression,
these double controls prevent leakage at the transcriptional level,
which could be particularly suitable for stable mRNAs like spa.
Therefore, the involvement of RNAIII in such regulatory circuits
not only guarantees tight regulation but also might ensure fast
recovery after the external stimulus (quorum sensing) is over [57].
Hence, a number of genes—and the list will likely grow—are
regulated by RNAIII at multiple levels (indirectly on promoter
activity, directly on translation and mRNA degradation), suggest-
ing that the amount and timing of production of certain virulence
factors is precisely controlled during the course of infection. The in
vivo requirement for such strict regulation of virulence protein
expression is particularly plausible in the case of the protein A,
which harbors multiple functions from anti-opsonic activity to the
induction of tumor necrosis factor receptor 1 and B cell
superantigenic properties [58,59].
The importance of agr for S. aureus pathogenesis is the subject of
an apparent paradox. In contrast with most other staphylococcal
sRNAs, which have been found by bioinformatic approaches or
deep sequencing, RNAIII was first identified in a transposon
mutagenesis that revealed pleiotropic effects of a single-site
insertion [60,61]. Because of its impact on virulence factors, the
agr system and its effector molecule RNAIII were thought to be of
major importance for virulence. Indeed, the majorities of clinical
isolates from acute infections have a functional agr system and
produce RNAIII both in vitro and in vivo [62]. However, agr-
defective mutant strains, which arose during infection, were
isolated from patients [62]. Some of these strains have been
associated with persistent bacteremia, notably in patients with
intravascular devices and with reduced susceptibility to glycopep-
tides [63,64]. Agr defects are also detected in colonizing isolates of
patients, and a mixture of agr-positive and agr-defective S. aureus
strains were described in healthy humans [65]. This supports the
model of agr being important for full expression of virulence,
notably during acute infection, whilst agr mutants would be
positively selected in chronic infections and dormant states.
However, the observation that RNAIII is also present in all
Figure 3. The functional RNAIII structure and its mRNA targets. (A) Schematic view of the RNAIII-mediated antisense activation mechanism.
Hairpin loops H2 and H3 of RNAIII (red) bind to the hla mRNA (black) to activate translation initiation. The ribosomal 30S subunit is schematized. The
SD sequence is green. (B) RNAIII secondary structure (adapted from [52]) and its genomic location within the agr locus (bottom). RNAIII encodes the
delta-hemolysin (hld, in green). The 59UTR activates alpha-hemolysin translation [54] and the 39 domain represses the translation of virulence factors
and of the transcriptional repressor of toxins (rot) [13,34]. The conserved C-rich sequences detected in H7, H13, and H14 is indicated. (C) Schematic
views of the RNAIII-mediated antisense translation initiation repression mechanisms. RNAIII structural domains H7, H13, and H14 (in red) are involved
in interactions with target mRNAs (in black). The AUG codon and SD sequence are in green. The broken black arrows are the RNase III–induced
cleavages.
doi:10.1371/journal.ppat.1002006.g003
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nosocomial pathogen, highlights the fact that RNAIII is not solely
a determinant of acute virulence but harbors various functions
depending on the bacterial species background in which it evolved.
Interestingly, the most conserved domain of RNAIII among
staphylococcal species is the 39 domain (H13 and H14), which is
involved in the regulation of several S. aureus–specific virulence
factors (see above). Its conservation in S. epidermidis, S. lugdunensis,
and other species suggests that some of the target genes, such as
those involved in peptidoglycan metabolism, require the presence
of this regulatory domain [52,66].
trans-Acting RNAs in Stress Response and
Metabolism
Ongoing functional characterization of S. aureus sRNAs links
them to various environmental and stress-related responses like pH
and temperature variations, nutrient starvation, oxidative stress,
and quorum sensing, all of which can be encountered during host
infection [15–18,21]. Such environmental stresses and growth
conditions largely influence the toxin synthesis [67] and require
several global transcriptional regulators, such as the alternative
sigma B factor (s
B). The s
B regulon consists of numerous genes
involved in metabolism, stress-related responses, membrane
transport system, biofilm formation, antibiotic resistance, and
virulence [68,69]. Among these genes, several were repressed by
s
B via an indirect mechanism most probably involving a s
B-
induced regulatory protein or sRNA. Along those lines, recent
studies showed that the expression of several sRNAs was induced
by s
B [15,70]; among them, RsaA, which has a typical s
B-
promoter detected upstream of its corresponding gene [15]. RsaA,
conserved among staphylococci, can potentially base pair with
mRNAs repressed by s
B like citM encoding an Mg-citrate
transporter (Figure 2; [68]). Prediction of s
B-promoter within
intergenic regions of the S. aureus genome suggests the existence of
additional s
B-dependent sRNAs, which awaits experimental
validation [15,18]. Three s
B-dependent sRNAs that are highly
conserved in S. aureus have been recently described [71], and two
of them are predicted to encode small highly basic peptides
[18,71].
Most of the newly identified sRNAs are conserved among S.
aureus clinical isolates or are expressed in various staphylococcal
strains [14,15,17,18]. One exception is the sRNA RsaE for which
the sequence and structure have been found strictly conserved in
the Staphylococcus, Macrococcus, and Bacillus genera, all of which
share a common Gram-positive ancestor (Figure 2; [15]). The
overproduction of RsaE causes a growth defect that is partially
alleviated by the non-preferred carbon source, acetate, suggesting
that RsaE accumulation alters essential metabolic functions [17].
Using comparative transcriptomic and proteomic analysis, RsaE
Figure 4. Integrating the S. aureus sRNAs into gene regulation cascades. The ‘‘agr-RNAIII’’ auto-activation circuit is indicated with the two
feed-forward loops involving RNAIII. When reaching optimal density, the autoinducing peptide (AIP) activates the agr autocatalytic circuit, leading to
RNAIII transcription. RNAIII represses the expression of rot, which activates spa transcription and represses that of hla. In the meantime, RNAIII also
activates hla mRNA translation and represses spa mRNA translation. The plain and broken lines indicate the direct or indirect gene activations,
respectively. The red lines indicate the down-regulations mediated by the various RNAs. The black question marks above the ‘‘see-sawing’’ triangles
point to the unknown triggering factors. The transcriptional regulatory proteins are in blue. The complexity of this scheme will certainly increase as
we learn more on the sRNA functions.
doi:10.1371/journal.ppat.1002006.g004
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pathways involved in amino acid and peptide transport (opp-3
operon), cofactor synthesis, folate-dependent one-carbon metab-
olism, lipid and carbohydrate metabolism, and the tricarboxylic
acid (TCA) cycle [15,17]. Like RNAIII, a conserved and
unpaired C-rich motif within RsaE pairs with the SD sequence
of several target mRNAs, including opp-3B/opp-3A (amino acid
and peptide transporter), sucC (succinyl-CoA synthetase of the
TCA cycle), and SA0873 (unknown function), all preventing
ribosomal initiation complex formation (Figure 2; [15,17]). Thus,
RsaE would coordinate down-regulation of energy metabolism
(via the TCA cycle) and purine biosynthesis when carbon sources
become scarce, facilitating adaptation to the entry into stationary
phase (Figure 4). The TCA cycle is integrally involved in the
regulation of virulence factor synthesis, biofilm formation and
antibiotic resistance (for a review, see [67]). Other sRNAs are
probably involved in metabolic regulation (Figure 4). For
instance, carbohydrate-dependent repression and oxygen avail-
ability correlate with altered expression of RNAIII [67].
Although no iron-dependent sRNA was so far identified in S.
aureus as in Gram-negative bacteria [65], S. aureus sense the
alteration of iron status via the ferric uptake regulator (Fur),
initiating a regulatory program that modifies expression of a large
number of virulence factors [72]. The ongoing functional analysis
of the S. aureus sRNAs will provide a clearer picture of the links
between sRNAs, metabolism, stress adaptation, and virulence
programming.
RNAs as Antimicrobial Drug Targets
The continued evolution of anti-microbial resistance in hospitals
and the emergence of community-associated MRSA strains are
major threats to patient care. Current antibiotic drugs target a
narrow spectrum of bacterial functions including peptidoglycan
biogenesis, DNA replication, and protein synthesis. Therefore,
there is a growing need for selecting new drugs that target other
cellular pathways that should, in principle, result in a weaker
selective pressure for the appearance of antibiotic resistance, and
that can preserve the host endogenous microbiome. As alternative
strategies that affect bacterial viability, anti-virulence strategies
have been developed to target mechanisms leading to successful
infections, such as virulence factors causing host damage and
disease [73]. Among all the antibiotics currently used to treat
clinical infections, more than half bind to the ribosomal RNAs
[74]. Their success as antibacterial targets encourages the
development of new antibacterial drugs based on regulatory
structured sRNAs. Metabolite-sensing mRNAs, the so-called
riboswitches, have been recently exploited as drug targets since
they have evolved structured receptors to bind small metabolites
with high selectivity and to control the expression of downstream
essential genes [75].
Riboswitches are located in the 59UTRs of some mRNAs and
exhibit a structured receptor domain specifically recognized by a
small compound. Metabolite binding induces a conformational
change of the downstream mRNA that provokes either premature
transcription, translation repression, or RNA degradation. In S.
aureus, seven operons and 33 genes are under the control of
riboswitches that respond to the intracellular concentration of S-
adenosylmethionine (SAM) (Figure 1A), thiamine pyrophosphate
(TPP), flavin mononucleotide (FMN), lysine, glycine, guanine, 7-
aminomethyl-7-deazaguanine (preQ1), and glucosamine-6-phos-
phate (Glc-6P) [15,17,18,20,75]. Any agonistic molecule targeting
one of these riboswitches would likely impact gene regulation even
if cells are devoid of the natural metabolite. As a proof of principle,
and based on the crystal structure of the guanine receptor binding
domain [76,77], several rationally designed guanine analogues
that bind the purine riboswitch with affinities comparable to that
of the natural ligand were shown to inhibit B. subtilis growth [78].
In S. aureus, the guanine riboswitch regulates expression of the
operon, including xpt, pbuX, guaB, and guaA. Using the same
strategy as Kim et al. [78], a novel pyrimidine derivative, 2,5,6-
triaminopyrimidin-4-one (PC1), was designed to bind the purine-
sensing riboswitch to repress the downstream genes [79]. For the
first time, this work shows that PC1 has a selective bactericidal
activity restricted to a sub-group of bacteria including S. aureus,
which contains guaA under the control of the purine riboswitch.
Although the GMP synthase GuaA is not essential for growth in
rich media, the enzyme is nevertheless an important contributor to
S. aureus survival during infection [79]. The administration of PC1
significantly reduced S. aureus infection in a murine model [79].
The narrow spectrum of bactericidal activity of PC1 also has the
advantage of reducing the selective pressure for resistance. This
work and the fact that S. aureus contains other types of riboswitches
offer novel opportunities for the design of drugs that inhibit the
function of structured regulatory RNAs. The increasing rate of S.
aureus sRNA discovery, together with the intensified search for
their mechanisms of action, should pave the way to exploit
chemical strategies to interfere with sRNA functions and to fight
against bacterial infections in a more specific way.
Concluding Remarks
This review provides a first hint at sRNA functions in S. aureus
and shows that we are just beginning to fully appreciate their roles
in gene regulation. The combined use of high throughput genomic
methods and phenotypic analyses of S. aureus strains mutated for
the sRNA genes, regulatory proteins, ribonucleases, and RNA-
binding proteins will generate knowledge on how the regulatory
RNAs and proteins are integrated into intertwined regulatory
networks in stress adaptation and virulence (Figure 4). However,
complications are expected due to the substantial genetic
variability between S. aureus strains, which express a subset of
regulatory RNAs, or unique RNAs, and are thus far from
universal [14,15].
Future research is also necessary to identify the signals that
regulate sRNA transcription and the mechanisms by which sRNAs
act on their targets. To date, most identified mechanisms have
involved trans-acting sRNAs that bind to the RBS of mRNA
targets, and only SprA was predicted to bind to the 39UTRs.
Binding to the coding sequence has not yet been observed. While
scientific interest has been mainly focused on antisense regulation,
regulatory RNAs are also expected to target proteins. For instance,
direct interaction of S. aureus 6S RNA with the polymerase bound
to s
A and its implication in virulence needs to be analyzed.
Multifunctional RNAs, like RNAIII, are most probably the rule
rather than the exception, and this field is at present completely
unexplored. We also need to consider other unexpected
possibilities such as RNA-activating virulence factors, or bacterial
sRNAs targeting host genes. Recent analysis of the MRSA operon
also shows that many mRNAs have long UTRs, more frequently
found at the 39 ends [80]. These regions might have implications
in regulation by promoting specific binding sites for trans-acting
ligands or by their processing to generate sRNAs [18].
Mechanisms of RNA processing and turnover are not well studied
in S. aureus and little is known about S. aureus RNA-binding
proteins associated with sRNAs.
This review illustrates the great diversity in sizes, structures, and
mechanisms of sRNAs, and shows that determinants required for
PLoS Pathogens | www.plospathogens.org 8 March 2011 | Volume 7 | Issue 3 | e1002006regulation could sometimes be predicted from the RNA structure.
For instance, several sRNAs and RNAIII carry a C-rich motif,
located in hairpin loops or in accessible single strands, which is a
specific recognition signature to target the mRNA RBS [13,15].
Determination of the structures of regulatory complexes has paved
the way to identify novel drugs that could interfere with RNA
functions [79]. Also, the significant contribution of RNAIII and
SprD to cause diseases in animal models of infection implies that
these RNAs could be promising drug targets.
Another aspect, which might be important for virulence and
host adaptation, would be to consider the cell differentiation
within a population, as well as cell-to-cell communication. The
expression of individual sRNAs might be variable within a
population and these differences could confer the ability of a
bacterial subpopulation to respond to stress or environmental
changes. This is particularly true for biofilm formation. Further-
more, we have no idea how the host ‘‘microbiome’’ influences
sRNA expression and their regulatory networks within S. aureus,
and vice versa. Metagenomics and deep sequencing could address
these questions and would contribute to an understanding of how
commensal bacteria can cause diseases.
The recently identified S. aureus RNome (listed in Table S1)
reveals additional layers of complexity to gene regulation
mechanisms. sRNA-based regulation increases the number of
possible regulatory sites and expectedly provides several advan-
tages compared to protein-based regulation [81]. Since many
sRNAs act at transcription termination or when translation starts,
fast and efficient responses on protein levels can be achieved.
Furthermore, it is also easier to control RNA turnover when
compared to protein degradation. To date, the known S. aureus
regulatory RNAs provide functional links between metabolism,
quorum sensing, and virulence (Figure 4). As we learn more about
sRNA functions, we expect to find more sRNAs involved in S.
aureus pathogenesis as well as other connections between virulence
and housekeeping networks.
Supporting Information
Table S1 Compilation of 91 expressed RNAs forming the S.
aureus RNome. It includes 18 cis-acting regulators including
riboswitches (green), 7 cis-encoded sRNAs (purple) 47 trans-
encoded RNAs (pink), 10 repeated sequences (yellow), and 9
potential 59UTRs, 39UTRs, or small CDSs. Both the gene and
RNA names, their experimental confirmations, strand expression,
genomic locations, predicted lengths, flanking and/or antisense
genes, expression profiles, and conservations are indicated for each
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